QuidelOrtho Corporation
General ticker "QDEL" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.7B (TTM average)
QuidelOrtho Corporation does not follow the US Stock Market performance with the rate: -9.8%.
Estimated limits based on current volatility of 3.5%: low 17.43$, high 18.41$
Factors to consider:
- Earnings expected soon, date: 2026-07-29 amc
- Total employees count: 6500 (-1.5%) as of 2025
- US accounted for 56.4% of revenue in the fiscal year ended 2024-12-29
- Top business risk factors: Market competition, R&D failure, Market demand decline, Supply chain disruptions, Regulatory and compliance
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-28 to 2027-12-28
- 2025-12-28 to 2026-12-28 estimated range: [16.67$, 34.60$]
- 2026-12-28 to 2027-12-28 estimated range: [15.38$, 32.16$]
Short-term QDEL quotes
Long-term QDEL plot with estimates
Financial data
| YTD | 2025-12-28 |
|---|---|
| Operating Revenue | $2,730.20MM |
| Operating Expenses | $3,649.40MM |
| Operating Income | $-919.20MM |
| Non-Operating Income | $-188.50MM |
| Interest Expense | $177.60MM |
| R&D Expense | $186.20MM |
| Income(Loss) | $-1,107.70MM |
| Taxes | $24.10MM |
| Net Income(Loss)* | $-1,131.80MM |
| Stockholders Equity | $1,920.50MM |
| Inventory | $577.60MM |
| Assets | $5,769.30MM |
| Operating Cash Flow | $105.20MM |
| Capital expenditure | $188.20MM |
| Investing Cash Flow | $-192.70MM |
| Financing Cash Flow | $155.80MM |
| Earnings Per Share** | $-16.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.